UPMC Outpatient Center South Side is a hub for COVID-19 mitigation efforts, from testing to vaccinating to treating. The facility is one of many UPMC sites that offers monoclonal antibody treatments, which work to prevent people infected with COVID-19 from becoming seriously ill.
With expanded eligibility for monoclonal antibody treatments announced by the U.S Food and Drug Administration last month, many patients now have quick access to the life-saving therapy. Patients are advised to ask their doctor about the treatment as soon as they think they have contracted COVID-19. Early action is key in thwarting the complications of COVID-19 with monoclonal antibodies.
Further information about mitigation efforts at UPMC Outpatient Center South Side can be found here. Additional information about monoclonal antibody treatment is available on UPMC’s website.
